A detailed history of Avestar Capital, LLC transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Avestar Capital, LLC holds 3,198 shares of TMO stock, worth $1.68 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
3,198
Previous 2,984 7.17%
Holding current value
$1.68 Million
Previous $1.65 Million 19.88%
% of portfolio
0.21%
Previous 0.17%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$531.86 - $624.21 $113,818 - $133,580
214 Added 7.17%
3,198 $1.98 Million
Q2 2024

Aug 08, 2024

BUY
$541.52 - $599.02 $569,679 - $630,169
1,052 Added 54.45%
2,984 $1.65 Million
Q1 2024

May 10, 2024

BUY
$528.82 - $599.43 $285,033 - $323,092
539 Added 38.69%
1,932 $1.12 Million
Q4 2023

Feb 12, 2024

BUY
$431.41 - $532.94 $111,303 - $137,498
258 Added 22.73%
1,393 $739,000
Q3 2023

Oct 20, 2023

BUY
$498.29 - $574.41 $76,238 - $87,884
153 Added 15.58%
1,135 $574,000
Q2 2023

Aug 01, 2023

BUY
$508.46 - $591.13 $15,253 - $17,733
30 Added 3.15%
982 $512,000
Q1 2023

Apr 20, 2023

BUY
$535.0 - $604.82 $33,170 - $37,498
62 Added 6.97%
952 $548,000
Q4 2022

Jan 20, 2023

SELL
$484.71 - $571.37 $27,143 - $31,996
-56 Reduced 5.92%
890 $0
Q3 2022

Oct 26, 2022

BUY
$507.19 - $604.49 $57,819 - $68,911
114 Added 13.7%
946 $480,000
Q2 2022

Jul 28, 2022

BUY
$500.9 - $612.21 $4,508 - $5,509
9 Added 1.09%
832 $452,000
Q1 2022

Apr 26, 2022

BUY
$524.0 - $644.92 $89,080 - $109,636
170 Added 26.03%
823 $486,000
Q4 2021

Feb 01, 2022

SELL
$569.0 - $667.24 $19,346 - $22,686
-34 Reduced 4.95%
653 $436,000
Q3 2021

Nov 09, 2021

SELL
$509.53 - $609.78 $6,623 - $7,927
-13 Reduced 1.86%
687 $393,000
Q2 2021

Aug 03, 2021

BUY
$441.0 - $508.24 $8,820 - $10,164
20 Added 2.94%
700 $353,000
Q1 2021

May 03, 2021

BUY
$439.85 - $518.83 $9,236 - $10,895
21 Added 3.19%
680 $330,000
Q4 2020

Feb 01, 2021

BUY
$435.06 - $527.66 $16,532 - $20,051
38 Added 6.12%
659 $307,000
Q3 2020

Oct 29, 2020

SELL
$359.77 - $441.52 $35,617 - $43,710
-99 Reduced 13.75%
621 $300,000
Q2 2020

Jul 29, 2020

SELL
$275.2 - $362.34 $12,659 - $16,667
-46 Reduced 6.01%
720 $261,000
Q1 2020

May 12, 2020

BUY
$255.3 - $340.05 $6,127 - $8,161
24 Added 3.23%
766 $217,000
Q4 2019

Feb 14, 2020

SELL
$271.93 - $328.04 $543 - $656
-2 Reduced 0.27%
742 $241,000
Q3 2019

Nov 14, 2019

BUY
$268.46 - $305.43 $62,014 - $70,554
231 Added 45.03%
744 $217,000
Q2 2019

Aug 06, 2019

SELL
$257.51 - $295.55 $14,420 - $16,550
-56 Reduced 9.84%
513 $130,000
Q1 2019

May 09, 2019

SELL
$212.17 - $273.72 $15,064 - $19,434
-71 Reduced 11.09%
569 $134,000
Q4 2018

Jan 25, 2019

SELL
$208.47 - $251.98 $16,469 - $19,906
-79 Reduced 10.99%
640 $125,000
Q3 2018

Oct 23, 2018

BUY
$205.57 - $244.32 $9,867 - $11,727
48 Added 7.15%
719 $152,000
Q2 2018

Aug 10, 2018

BUY
$203.14 - $219.53 $7,313 - $7,903
36 Added 5.67%
671 $115,000
Q1 2018

May 10, 2018

BUY
$192.98 - $224.11 $12,157 - $14,118
63 Added 11.01%
635 $110,000
Q4 2017

Feb 14, 2018

BUY
$182.03 - $200.37 $104,121 - $114,611
572
572 $93,000

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $205B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Avestar Capital, LLC Portfolio

Follow Avestar Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avestar Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avestar Capital, LLC with notifications on news.